We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
276
Ametek
AME
$54.6B
$5.17M 0.05%
31,033
-359
-1% -$62K
HUBS icon
277
HubSpot
HUBS
$13.1B
$5.17M 0.05%
8,766
+342
+4% +$210K
ULTA icon
278
Ulta Beauty
ULTA
$22.3B
$5.14M 0.05%
13,326
-614
-4% -$250K
ALNY icon
279
Alnylam Pharmaceuticals
ALNY
$31.4B
$5.12M 0.05%
21,076
+1,378
+7% +$218K
BR icon
280
Broadridge
BR
$21B
$5.09M 0.05%
25,853
+1,054
+4% +$209K
ACGL icon
281
Arch Capital
ACGL
$33.6B
$5.06M 0.05%
50,113
-5,509
-10% -$536K
NUE icon
282
Nucor
NUE
$56.7B
$5.02M 0.05%
31,773
-1,100
-3% -$191K
PEG icon
283
Public Service Enterprise Group
PEG
$36.3B
$5M 0.05%
67,838
-153
-0.2% -$10.9K
BKR icon
284
Baker Hughes
BKR
$62B
$4.95M 0.05%
140,677
-2,389
-2% -$78.4K
TEAM icon
285
Atlassian
TEAM
$48.9B
$4.94M 0.05%
27,913
+866
+3% +$155K
VEEV icon
286
Veeva Systems
VEEV
$45.4B
$4.91M 0.05%
26,856
+119
+0.4% +$23.6K
NTAP icon
287
NetApp
NTAP
$36.9B
$4.89M 0.05%
37,971
+1,234
+3% +$139K
BIIB icon
288
Biogen
BIIB
$32.1B
$4.89M 0.05%
21,081
+45
+0.2% +$9.78K
LEN icon
289
Lennar Class A
LEN
$20.5B
$4.87M 0.05%
33,536
-453
-1% -$68.9K
GIS icon
290
General Mills
GIS
$22.2B
$4.84M 0.05%
76,515
-2,098
-3% -$144K
GEHC icon
291
GE HealthCare
GEHC
$32.4B
$4.82M 0.05%
61,879
+3,004
+5% +$245K
KDP icon
292
Keurig Dr Pepper
KDP
$44B
$4.82M 0.05%
144,260
+2,727
+2% +$90.5K
EXC icon
293
Exelon
EXC
$45.1B
$4.81M 0.05%
138,857
-6,737
-5% -$249K
AXON
294
Axon Enterprise
AXON
$49.2B
$4.76M 0.05%
16,178
+503
+3% +$150K
ED icon
295
Consolidated Edison
ED
$39.7B
$4.73M 0.05%
52,936
+7
+0% +$649
KVUE icon
296
Kenvue
KVUE
$36.8B
$4.73M 0.05%
260,072
-27,074
-9% -$525K
EFX icon
297
Equifax
EFX
$23B
$4.72M 0.05%
19,481
-5,918
-23% -$1.41M
TPL icon
298
Texas Pacific Land
TPL
$25.1B
$4.7M 0.05%
19,197
-135
-0.7% -$28.3K
HIG icon
299
Hartford Financial Services
HIG
$37.4B
$4.68M 0.05%
46,526
+276
+0.6% +$27.7K
PINS icon
300
Pinterest
PINS
$13.1B
$4.67M 0.05%
105,895
+834
+0.8% +$32.9K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.